Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 3
2009 3
2010 1
2011 1
2012 2
2013 3
2014 1
2015 1
2017 2
2018 1
2019 1
2020 1
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Clinical efficacy of plasmid encoding p62/SQSTM1 (Elenagen) in combination with gemcitabine in patients with platinum-resistant ovarian cancer: a randomized controlled trial.
Krasny S, Baranau Y, Polyakov S, Zharkova E, Streltsova O, Filimonava A, Siarheyeva V, Kazlouskaya S, Khorau A, Gabai V, Shneider A. Krasny S, et al. Among authors: shneider a. Front Oncol. 2024 Feb 12;14:1343023. doi: 10.3389/fonc.2024.1343023. eCollection 2024. Front Oncol. 2024. PMID: 38410116 Free PMC article.
p62 /SQSTM1 coding plasmid prevents age related macular degeneration in a rat model.
Kolosova NG, Kozhevnikova OS, Telegina DV, Fursova AZ, Stefanova NA, Muraleva NA, Venanzi F, Sherman MY, Kolesnikov SI, Sufianov AA, Gabai VL, Shneider AM. Kolosova NG, et al. Among authors: shneider am. Aging (Albany NY). 2018 Aug 28;10(8):2136-2147. doi: 10.18632/aging.101537. Aging (Albany NY). 2018. PMID: 30153656 Free PMC article.
P62 plasmid can alleviate diet-induced obesity and metabolic dysfunctions.
Halenova T, Savchuk O, Ostapchenko L, Chursov A, Fridlyand N, Komissarov AB, Venanzi F, Kolesnikov SI, Sufianov AA, Sherman MY, Gabai VL, Shneider AM. Halenova T, et al. Among authors: shneider am. Oncotarget. 2017 Aug 3;8(34):56030-56040. doi: 10.18632/oncotarget.19840. eCollection 2017 Aug 22. Oncotarget. 2017. PMID: 28915571 Free PMC article.
Safety and efficacy of p62 DNA vaccine ELENAGEN in a first-in-human trial in patients with advanced solid tumors.
Ponomarenko DM, Klimova ID, Chapygina YA, Dvornichenko VV, Zhukova NV, Orlova RV, Manikhas GM, Zyryanov AV, Burkhanova LA, Badrtdinova II, Oshchepkov BN, Filippova EV, Orlov SV, Kolesnikov SI, Sufianov AA, Baum SR, Zaitzeva OY, Komissarov AB, Grudinin MP, Kiselev OI, Tsyb AF, Venanzi F, Shcherbinina V, Chursov A, Gabai VL, Shneider AM. Ponomarenko DM, et al. Among authors: shneider am. Oncotarget. 2017 Mar 25;8(32):53730-53739. doi: 10.18632/oncotarget.16574. eCollection 2017 Aug 8. Oncotarget. 2017. PMID: 28881846 Free PMC article.
Plasmid DNA-coding p62 as a bone effective anti-inflammatory/anabolic agent.
Sabbieti MG, Agas D, Capitani M, Marchetti L, Concetti A, Vullo C, Catone G, Gabai V, Shifrin V, Sherman MY, Shneider A, Venanzi FM. Sabbieti MG, et al. Among authors: shneider a. Oncotarget. 2015 Feb 28;6(6):3590-9. doi: 10.18632/oncotarget.2884. Oncotarget. 2015. PMID: 25668818 Free PMC article.
25 results